logo
  

Hudson's Bay Partners With Real Estate Firms To Create JVs Valued At C$4.2 Bln

Hudson's Bay Co. (HBC.TO) said it has entered into agreements with Simon Property Group Inc. (SPG) and RioCan Real Estate Investment Trust (REI.UN_TO) to form two joint ventures focused on real estate growth opportunities in the U.S. and Canada, respectively. The ventures are valued at C$4.2 billion.

The C$1.1 billion in expected cash proceeds from the joint venture transactions, net of expenses, will be used to reduce debt on HBC's balance sheet.

These joint ventures will enable HBC to leverage the expertise of market leading real estate companies to build on the strength of its existing real estate assets and identify new real estate growth opportunities. The transactions are structured to facilitate an IPO or other monetization transaction of each joint venture at a later date.

Each transaction has been approved by HBC's board of directors. Both transactions are expected to close in 90 days.

The management values HBC's total real estate portfolio at over C$9 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT